We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAL:LSESpaceandPeople plc Analysis

Data as of 2026-06-14 - not real-time

£152.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

SpaceandPeople plc trades at £152.5, well below its 200‑day SMA of £199.3 and the DCF‑derived fair value of £768, implying an upside of over 100%. The stock is in a deep oversold condition with an RSI of 25.6 and a bearish MACD histogram, while volume is shrinking, suggesting short‑term pressure near the identified support at £147. Despite the technical weakness, fundamentals are solid: revenue grew 14% YoY, gross margins exceed 80%, and the company generates ample operating cash flow relative to its modest debt load, reflected in a low PE of 8 versus an industry average of 17. The combination of strong cash generation, attractive valuation multiples and a niche promotional‑space business in the UK and Germany points to a compelling long‑term investment case, though liquidity constraints and sector cyclicality warrant caution in the near term.
Given the extreme market optimism (Fear & Greed Index at “Extreme Greed”) and the massive valuation gap, patient investors could benefit from a position now, while short‑term traders may prefer to wait for a clearer technical breakout.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicates oversold conditions but price remains below key moving averages
  • Decreasing volume and proximity to support level
  • Large valuation gap suggests potential for volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Low PE relative to industry and strong cash generation
  • Revenue growth of 14% and high gross margins
  • Upside potential exceeds 100% based on DCF fair value

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable business model in promotional retail space across UK and Germany
  • Robust balance sheet with low debt and high free cash flow
  • Undervaluation reflected in multiple metrics (PE, PB, price-to-sales) and DCF analysis

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin5.13%
P/E Ratio8.0
ROE11.18%
ROA3.47%
Debt/Equity15.87
P/B Ratio0.8
Op. Cash Flow£1.3M
Free Cash Flow£580.9K
Industry P/E17.0

Technical Analysis

TrendBearish
RSI25.6
Support£147.00
Resistance£168.00
MA 20£161.00
MA 50£173.70
MA 200£199.31
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value£768.37
Target Price£310.00
Upside/Downside103.28%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.34
Volatility25.18%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.